Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial)

NCT00098137 is registered in ClinicalTrials.gov with Atrial Fibrillation Network as lead sponsor.

NCT NCT00098137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial)
Lead sponsor
Atrial Fibrillation Network
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2009
Enrollment
422 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation, heart disease